Literature DB >> 25411062

Correlation of advanced glycation endproducts estimated from skin fluorescence in first-degree relatives: the impact of adjustment for skin pigmentation.

Eileen A Báez1, Shreepal Shah1, Dania Felipe1, John Maynard2, Stuart Chalew3.   

Abstract

The objective was to assess the relationship of skin advanced glycation endproducts (AGEs) between first-degree relatives estimated from skin fluorescence (SF) after adjustment for skin pigmentation. SF was excited by LEDs centered at 375, 405, and 420 nm from children with type 1 diabetes and their mothers. Data were adjusted to generate measures of skin intrinsic fluorescence (SIF) at the various excitation wavelengths, using 2 different pairs of correction coefficients for excitation (kx) and emission (km): kx = 0.5, km = 0.5 (not associated with skin pigmentation) and kx = 1.0, km = 0.0 (strongly associated with skin pigmentation). Pearson correlation analysis was performed, as well as a multiple variable analysis with maternal SIF adjusted for the effects of maternal age and race. There were 50 matched pairs of children and their mothers. Children were 13.3 ± 3.7 years of age and there were 19 boys/31 girls and 15 black/35 white. Mothers were 41.8 ± 6.8 years of age. The age of mother and child was highly correlated, r = .64, P < .0001. In Pearson correlation analysis, child's SIF (kx = 1.0, km = 0.0) the had strongest association with maternal SIF, while with SIF (kx = 0.5, km = 0.5) there was a trend for association. In the multiple variable model child SIF was associated with maternal SIF for all corrections and wavelengths but was stronger for kx = 1.0, km = 0.0. Even after adjustment for skin pigmentation and race, correlation of SIF between family members persists, suggesting that other genetic and/or environmental factors shared by parent and child may influence estimated skin AGEs.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  advanced glycation endproducts; intrinsic fluorescence; skin fluorescence; type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25411062      PMCID: PMC4604586          DOI: 10.1177/1932296814559745

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

1.  The unexpected pathway to the creation of the HbA1c test and the discovery of AGE's.

Authors:  A Cerami
Journal:  J Intern Med       Date:  2012-02-14       Impact factor: 8.989

Review 2.  Advanced glycation endproducts and cigarette smoking.

Authors:  I D Nicholl; R Bucala
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1998-11       Impact factor: 1.770

3.  Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Authors:  Patricia A Cleary; Barbara H Braffett; Trevor Orchard; Timothy J Lyons; John Maynard; Catherine Cowie; Rose A Gubitosi-Klug; Jeff Way; Karen Anderson; Annette Barnie; Stephan Villavicencio
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

4.  Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.

Authors:  Saul Genuth; Wanjie Sun; Patricia Cleary; David R Sell; William Dahms; John Malone; William Sivitz; Vincent M Monnier
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

5.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.

Authors:  V M Monnier; O Bautista; D Kenny; D R Sell; J Fogarty; W Dahms; P A Cleary; J Lachin; S Genuth
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

Review 6.  Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.

Authors:  Jaime Uribarri; Weijing Cai; Oana Sandu; Melpomeni Peppa; Teresia Goldberg; Helen Vlassara
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

7.  Simple non-invasive assessment of advanced glycation endproduct accumulation.

Authors:  R Meerwaldt; R Graaff; P H N Oomen; T P Links; J J Jager; N L Alderson; S R Thorpe; J W Baynes; R O B Gans; A J Smit
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

8.  Level of an advanced glycated end product is genetically determined: a study of normal twins.

Authors:  R David G Leslie; Huriya Beyan; Pam Sawtell; Bernard O Boehm; Tim D Spector; Harold Snieder
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

9.  Accumulation of Maillard reaction products in skin collagen in diabetes and aging.

Authors:  D G Dyer; J A Dunn; S R Thorpe; K E Bailie; T J Lyons; D R McCance; J W Baynes
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.

Authors:  Karen M Eny; Helen L Lutgers; John Maynard; Barbara E K Klein; Kristine E Lee; Gil Atzmon; Vincent M Monnier; Jana V van Vliet-Ostaptchouk; Reindert Graaff; Pim van der Harst; Harold Snieder; Melanie M van der Klauw; David R Sell; S Mohsen Hosseini; Patricia A Cleary; Barbara H Braffett; Trevor J Orchard; Timothy J Lyons; Kerri Howard; Ronald Klein; Jill P Crandall; Nir Barzilai; Sofiya Milman; Danny Ben-Avraham; Bruce H R Wolffenbuttel; Andrew D Paterson
Journal:  Diabetologia       Date:  2014-06-17       Impact factor: 10.122

View more
  1 in total

1.  New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.

Authors:  Delnaz Roshandel; Ronald Klein; Barbara E K Klein; Bruce H R Wolffenbuttel; Melanie M van der Klauw; Jana V van Vliet-Ostaptchouk; Gil Atzmon; Danny Ben-Avraham; Jill P Crandall; Nir Barzilai; Shelley B Bull; Angelo J Canty; S Mohsen Hosseini; Linda T Hiraki; John Maynard; David R Sell; Vincent M Monnier; Patricia A Cleary; Barbara H Braffett; Andrew D Paterson
Journal:  Diabetes       Date:  2016-04-12       Impact factor: 9.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.